| Mel-18 and Bmi-1 may regulate the Akt pathway in breast cancer cells, and that Mel-18 functions as a tumor suppressor by repressing the expression of Bmi-1 and consequently down-regulating Akt activity. | breast, |
| The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance. | prostate, |
| Mel-18 functions as a tumor suppressor by its novel negative control of the epithelial-mesenchymal transition in breast cancer. | breast, |
| MEL-18, a tumor suppressor for aggressive breast cancer | breast, |
| BMI1 acts as an oncogene and Mel-18 functions as a tumor suppressor via downregulation of BMI1. | None |
| The oncogenic role of MEL-18 in human primary breast carcinomas is determined by its capacity to inhibit INK4a/ARF proteins(p16INK4a, p14ARF, or h-TERT) or to induce telomerase activity. | breast, |